These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17960796)

  • 1. Long-term follow-up of impulse control disorders in Parkinson's disease.
    Mamikonyan E; Siderowf AD; Duda JE; Potenza MN; Horn S; Stern MB; Weintraub D
    Mov Disord; 2008 Jan; 23(1):75-80. PubMed ID: 17960796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of patients with Parkinson disease and pathological gambling.
    Bharmal A; Lu C; Quickfall J; Crockford D; Suchowersky O
    Can J Neurol Sci; 2010 Jul; 37(4):473-7. PubMed ID: 20724254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
    Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho J;
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):30-37. PubMed ID: 30361296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
    Catalan MJ; Molina-Arjona JA; Mir P; Cubo E; Arbelo JM; Martinez-Martin P;
    J Neurol; 2018 Jun; 265(6):1279-1287. PubMed ID: 29557989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study.
    Wirth T; Goetsch T; Corvol JC; Roze E; Mariani LL; Vidailhet M; Grabli D; Mallet L; Pelissolo A; Rascol O; Brefel-Courbon C; Ory-Magne F; Arbus C; Bekadar S; Krystkowiak P; Marques A; Llorca M; Krack P; Castrioto A; Fraix V; Maltete D; Defebvre L; Kreisler A; Houeto JL; Tranchant C; Meyer N; Anheim M
    J Neurol; 2024 May; 271(5):2412-2422. PubMed ID: 38214756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.
    Antonini A; Barone P; Bonuccelli U; Annoni K; Asgharnejad M; Stanzione P
    J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):317-324. PubMed ID: 28315845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impulse control and related disorders in Parkinson's disease.
    Weintraub D; Nirenberg MJ
    Neurodegener Dis; 2013; 11(2):63-71. PubMed ID: 23038208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse Control Disorders in the Polish Population of Patients with Parkinson's Disease.
    Toś M; Grażyńska A; Antoniuk S; Siuda J
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629758
    [No Abstract]   [Full Text] [Related]  

  • 11. Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.
    Claassen DO; van den Wildenberg WP; Harrison MB; van Wouwe NC; Kanoff K; Neimat JS; Wylie SA
    Pharmacol Biochem Behav; 2015 Feb; 129():19-25. PubMed ID: 25459105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective cohort study of impulse control disorders in Parkinson's disease.
    Bastiaens J; Dorfman BJ; Christos PJ; Nirenberg MJ
    Mov Disord; 2013 Mar; 28(3):327-33. PubMed ID: 23283708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 7-year observation of the effect of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson's disease.
    Kim A; Kim YE; Kim HJ; Yun JY; Yang HJ; Lee WW; Shin CW; Park H; Jung YJ; Kim A; Ehm G; Kim Y; Jang M; Jeon B
    Parkinsonism Relat Disord; 2018 Nov; 56():3-8. PubMed ID: 30054182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of impulse control disorders in Parkinson disease.
    Corvol JC; Artaud F; Cormier-Dequaire F; Rascol O; Durif F; Derkinderen P; Marques AR; Bourdain F; Brandel JP; Pico F; Lacomblez L; Bonnet C; Brefel-Courbon C; Ory-Magne F; Grabli D; Klebe S; Mangone G; You H; Mesnage V; Lee PC; Brice A; Vidailhet M; Elbaz A;
    Neurology; 2018 Jul; 91(3):e189-e201. PubMed ID: 29925549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
    Biundo R; Weis L; Abbruzzese G; Calandra-Buonaura G; Cortelli P; Jori MC; Lopiano L; Marconi R; Matinella A; Morgante F; Nicoletti A; Tamburini T; Tinazzi M; Zappia M; Vorovenci RJ; Antonini A
    Mov Disord; 2017 Nov; 32(11):1557-1565. PubMed ID: 28960475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease.
    Kim J; Kim M; Kwon DY; Seo WK; Kim JH; Baik JS; Koh SB
    J Neurol; 2013 Feb; 260(2):429-37. PubMed ID: 22893307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity.
    Pettorruso M; Fasano A; De Risio L; Ricciardi L; Di Nicola M; Martinotti G; Janiri L; Bentivoglio AR
    J Neurol Sci; 2016 Mar; 362():344-7. PubMed ID: 26944176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study.
    Vela L; Martínez Castrillo JC; García Ruiz P; Gasca-Salas C; Macías Macías Y; Pérez Fernández E; Ybot I; Lopez Valdés E; Kurtis MM; Posada Rodriguez IJ; Mata M; Ruiz Huete C; Eimil M; Borrue C; Del Val J; López-Manzanares L; Rojo Sebastian A; Marasescu R
    J Neurol Sci; 2016 Sep; 368():150-4. PubMed ID: 27538621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy.
    Rossi PJ; De Jesus S; Hess CW; Martinez-Ramirez D; Foote KD; Gunduz A; Okun MS
    Parkinsonism Relat Disord; 2017 Nov; 44():13-17. PubMed ID: 28827010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.